International Clinical Research - Tennessee LLC
Murfreesboro, Tennessee, United States
Research institute in Murfreesboro, Tennessee
1035 N Highland Ave, Murfreesboro, TN 37130
About International Clinical Research - Tennessee LLC
"IC Research is a dedicated clinical research site in Murfreesboro, Tennessee (conveniently located 40 minutes south of Nashville) that conducts Phase II-IV clinical research studies in a variety of therapeutic areas for leading pharmaceutical companies."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Incyte Corporation
7
Dermira, Inc.
3
Pfizer
3
Acrotech Biopharma Inc.
2
Astellas Pharma Global Development, Inc.
2
Cassiopea SpA
2
Eli Lilly and Company
2
Sebacia, Inc.
2
Amgen
1
Bayer
1
Celgene
1
Clinical Trials at International Clinical Research - Tennessee LLC
During the past decade, International Clinical Research - Tennessee LLC conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 12 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 9 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
2015-04-01
2016-04-01
Completed
420
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)
2016-01-21
2018-04-11
Completed
708
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris
2016-03-09
2018-08-31
Completed
609
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
2016-12-27
2017-11-28
Completed
759
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
2017-03-21
2018-04-27
Completed
748
A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
2017-10-30
2018-11-07
Completed
491
Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris
2017-09-25
2018-04-10
Completed
168
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "International Clinical Research - Tennessee LLC" #1 sponsor was "Incyte Corporation" with 7 trials, followed by "Dermira, Inc." with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Acrotech Biopharma Inc." with 2 trials sponsored and "Astellas Pharma Global Development, Inc."
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "International Clinical Research - Tennessee LLC"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at International Clinical Research - Tennessee LLC
According to Clinical.Site data, the most researched conditions in "International Clinical Research - Tennessee LLC" are
"Acne Vulgaris" (7 trials), "Atopic Dermatitis" (6 trials), "Dermatitis, Atopic" (2 trials), "Hot Flashes" (2 trials) and "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "International Clinical Research - Tennessee LLC" in a lesser frequency.
Clinical Trials Intervention Types at International Clinical Research - Tennessee LLC
Most popular intervention types in "International Clinical Research - Tennessee LLC" are "Drug" (25 trials), "Other" (4 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Ruxolitinib cream" (4 trials), "Vehicle" (4 trials), "Vehicle cream" (3 trials) and "Abrocitinib 200 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at International Clinical Research - Tennessee LLC
The vast majority of trials in "International Clinical Research - Tennessee LLC" are
24 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at International Clinical Research - Tennessee LLC
Currently, there are NaN active trials in "International Clinical Research - Tennessee LLC".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in International Clinical Research - Tennessee LLC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in International Clinical Research - Tennessee LLC, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".